– We are a consortium of eight universities and leading research institutions, which provides open access to 60+ imaging instruments spanning the entire resolution range of interests for biological and preclinical studies, offers expertise for data visualization, training, and other support facilities for all national and international researchers.
Austrian BioImaging/CMI was founded in 2016.
What CMI is for?
– Correlated Multimodal Imaging
Apart from recent advances, no single imaging technology can provide holistic information about a given sample. This limitation can be overcome by combining and multimodally correlating imaging technologies because it gathers information about the same specimen with two or more complementary modalities that – combined – create a composite view of the sample. One of the strengths of Austrian BioImaging is the research and development of correlative multimodality imaging.
Why open access is important?
– With the emergence of new frontiers of opportunity, one of the key challenges for scientists is to gain access to specific imaging technologies that are either not available at their home institutions or for which expertise is lacking.
Austrian BioImaging/CMI was founded in response to this development. In addition, it provide as a platform for research, knoweldge exchange and scientific cooperation among researchers and industry in the field of biological and preclinical imaging.
How we address the grand societal challenges?
– Cutting-edge imaging technologies are one of the driving forces in modern biology and preclinical studies. They enable scientists to visualize biological samples at various scales and quantify their structure, molecular dynamics, physical properties, and chemical composition with unprecedented precision. They help not only to address grant societal challenges but also allow breakthrough biological discoveries and their translation into medical application.
Fight infectious diseases